Diabetes drug shows promise for healing hearts after attack
NCT ID NCT07169981
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed study looked at whether the diabetes drug empagliflozin (Jardiance) can help repair heart damage in diabetic patients who had a major heart attack. 200 participants took either 10 mg or 25 mg of the drug daily for 6 months. Researchers measured changes in heart size, pumping strength, and overall function to see if the drug improves heart remodeling.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
empagliflozin (Jardiance)
What this could lead to
If successful, this could show that empagliflozin helps repair heart damage after a heart attack in diabetic patients, potentially improving heart function and reducing future heart problems.
What could go wrong
This is a small, completed Phase 2 trial, so results are preliminary. The benefits seen may not be large or may not apply to all patients. The drug is already approved for diabetes and heart failure, so major new risks are unlikely, but side effects like dehydration or urinary infections are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ain Shams University Hospitals
Cairo, Egypt